This provider's $35.1M in total Medicare payments ranks in the 97th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 1158% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 184% in 2020
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $65.01 | $14.41 | 4.51x | $50.60 | $633.0K | 43.9K | 95 |
| 2015 | $64.42 | $14.27 | 4.51x | $50.15 | $473.9K | 33.2K | 86 |
| 2016 | $60.46 | $13.90 | 4.35x | $46.56 | $676.9K | 48.7K | 83 |
| 2017 | $84.97 | $19.56 | 4.34x | $65.41 | $1.9M | 95.7K | 112 |
| 2018 | $82.79 | $17.62 | 4.70x | $65.17 | $2.0M | 115.8K | 133 |
| 2019 | $65.10 | $13.65 | 4.77x | $51.45 | $1.7M | 125.3K | 125 |
| 2020 | $110.61 | $24.18 | 4.57x | $86.43 | $4.9M | 201.1K | 139 |
| 2021 | $91.45 | $22.15 | 4.13x | $69.30 | $7.3M | 329.2K | 166 |
| 2022 | $57.03 | $20.09 | 2.84x | $36.94 | $7.6M | 377.8K | 168 |
| 2023 | $53.96 | $17.19 | 3.14x | $36.77 | $8.0M | 463.4K | 199 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 40.2K | $3.1M | $77.17 | 2.95x |
| 82306 | Vitamin d-3 level | 67.0K | $2.1M | $31.22 | 4.43x |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 13.7K | $1.9M | $140.80 | 1.34x |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | 98.9K | $1.8M | $17.71 | 4.39x |
| 86769 | Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | 39.0K | $1.6M | $41.99 | 4.01x |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | 109.4K | $1.5M | $13.47 | 4.59x |
| 80053 | Blood test, comprehensive group of blood chemicals | 136.8K | $1.5M | $10.63 | 4.50x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 148.9K | $1.2M | $8.22 | 4.41x |
| 83036 | Hemoglobin a1c level | 102.3K | $1.0M | $10.25 | 4.38x |
| 87633 | Detection test for multiple types of respiratory virus | 2.5K | $1.0M | $415.24 | 4.46x |
| 82607 | Cyanocobalamin (vitamin b-12) level | 62.2K | $994.3K | $16.00 | 4.39x |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | 25.1K | $867.1K | $34.60 | 2.13x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 32.7K | $811.7K | $24.86 | 2.03x |
| 87581 | Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique | 21.8K | $756.3K | $34.64 | 1.48x |
| 87486 | Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique | 21.8K | $756.0K | $34.64 | 1.48x |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 3.6K | $717.5K | $196.79 | 7.02x |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | 4.8K | $673.2K | $139.98 | 1.35x |
| 84153 | Psa (prostate specific antigen) measurement, total | 33.4K | $658.8K | $19.74 | 4.40x |
| 0202U | Test for detection of respiratory disease-causing organisms from back of nose and throat (nasopharynx) specimen, 22 target organisms including severe acute respiratory syndrome coronavirus 2 | 1.6K | $570.8K | $357.88 | 4.20x |
| 84439 | Thyroxine (thyroid chemical), free | 52.1K | $499.2K | $9.58 | 4.38x |
This provider submits charges 3.78 times higher than what Medicare actually pays.
A markup ratio of 3.78x means for every $100 Medicare pays, this provider initially charges $378. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in NY for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Northwell Health Laboratories | New Hyde Park, NY | $299.4M | ⚠️ Flagged |
| Sunrise Medical Laboratories, Inc. | Hicksville, NY | $281.2M | ⚠️ Flagged |
| Lenco Diagnostic Laboratories,inc. | Brooklyn, NY | $101.5M | ⚠️ Flagged |
| Enzo Clinical Labs, Inc. | Farmingdale, NY | $100.1M | ⚠️ Flagged |
| Cblpath, Inc | Rye Brook, NY | $94.4M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data